NIH Awards Allele with Grant for the Development of Nanoantibody Therapies for Treating Sepsis


Oct 15, 2018--The National Institute of General Medical Sciences of NIH has awarded a Small Business Innovative Research grant to Allele Biotechnology and Pharmaceuticals to develop new single-domain nanoantibody therapies for the treatment of sepsis. Sepsis and septic shock are among the leading causes of death in intensive care units .



from Biotech News